Category: Diagnostics
Global Diagnostics
-
Medical Image Management
... at a CAGR of 6.1% over the analysis period 2024-2030. Picture Archiving & Communication Systems (PACS) Platform, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.7 ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Medical Connectors
... CAGR of 5.5% over the analysis period 2024-2030. Hospital & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.7 Billion by the end of ... Read More
-
Medical Imaging Information Systems
... 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Computed Tomography Modality, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$390.1 Million by ... Read More
-
Refurbished Medical Imaging Equipment
... 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. CT Scanners, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.9 Billion by the ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More
-
Endobronchial Ultrasound Biopsy Devices
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Transbronchial Aspiration Needles, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$334.8 Million by ... Read More
-
Vendor Neutral Archives
... at a CAGR of 6.5% over the analysis period 2024-2030. On-Premises Delivery, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$552.5 Million by the end of ... Read More
-
Breast Cancer Screening
... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Breast Imaging Technologies
... at a CAGR of 5.2% over the analysis period 2024-2030. Ionizing Technologies, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Fluoroscopy and Mobile C-Arms
... 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Fluoroscopy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end ... Read More
-
Blood Culture Tests
... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More
-
Carrier Screening
... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Cell Counting
... CAGR of 5.3% over the analysis period 2024-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end of the ... Read More
-
Cell Sorting
... CAGR of 9.2% over the analysis period 2024-2030. Cell Sorters, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis ... Read More
-
Medical Radiation Shielding
... at a CAGR of 5.0% over the analysis period 2024-2030. MRI Shielding Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$672.8 Million by the end ... Read More
-
Microfluidics
... 16.0% over the analysis period 2024-2030. Microfluidics Devices, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth ... Read More
-
In Vitro Diagnostics
... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More
-
MRI Systems
... CAGR of 5.9% over the analysis period 2024-2030. Closed MRI Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.6 Billion by the end of the ... Read More
-
PET-CT Scanners
... CAGR of 5.0% over the analysis period 2024-2030. Stationary PET-CT Scanners, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Pneumonia Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis ... Read More
-
Positive Material Identification
... at a CAGR of 6.5% over the analysis period 2024-2030. Positive Material Identification Equipment, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.2 Billion by the ... Read More
-
Surgical Imaging Technologies
... at a CAGR of 2.7% over the analysis period 2024-2030. Image Intensifier C-arms Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$3.4 Billion by the ... Read More
-
Radiosurgery and Radiotherapy Robots
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. X-Ray Based Robots, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$3.2 Billion by ... Read More
-
Western Blotting
... CAGR of 5.3% over the analysis period 2024-2030. Western Blotting Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the ... Read More
Research Assistance
